In a remarkable intersection of artificial intelligence and veterinary medicine, an Australian tech entrepreneur has pioneered a personalized cancer vaccine for his dog, Rosie. The innovative treatment, developed with the aid of ChatGPT and a team of scientists at the University of Latest South Wales (UNSW), has shown promising results in shrinking Rosie’s tumors and improving her quality of life.
Rosie, an eight-year-old staffy-shar pei mix, was diagnosed with mast cell cancer in 2024, a common tumor in dogs. Despite undergoing surgery and chemotherapy, the tumors persisted, and Rosie’s condition deteriorated. Determined to find another option, her owner, Paul Conyngham, turned to the power of AI, initiating a journey that would lead to a groundbreaking medical advancement.
Conyngham, an electrical and computing engineer and co-founder of Core Intelligence Technologies, leveraged his expertise and the capabilities of OpenAI’s ChatGPT to explore potential treatment avenues. “I went to ChatGPT and came up with a plan on how to do this,” he told The Australian. The chatbot suggested immunotherapy and genomic sequencing of the tumor, setting Conyngham on a path toward a bespoke vaccine.
He contacted the Ramaciotti Centre for Genomics at UNSW, funding the sequencing of Rosie’s tumor DNA. This data was then analyzed, comparing cancerous cells to healthy ones to identify unique mutations driving the cancer’s growth. Conyngham also utilized AlphaFold, an AI tool developed by Google’s DeepMind, to predict the structure of mutated proteins that could serve as targets for treatment. Fortune reports that while a suitable immunotherapy drug was identified, the pharmaceutical company refused to provide it for veterinary use.
This roadblock led to a collaboration with Páll Thordarson, director of UNSW’s RNA Institute, a pioneer in nanomedicine. Thordarson’s team utilized Conyngham’s data to design and create a custom mRNA vaccine in less than two months. This vaccine works by training Rosie’s immune system to recognize and attack her specific cancer cells. The Jerusalem Post noted that this is believed to be the first personalized cancer vaccine designed specifically for a dog.
Rosie received her first injection in December, followed by a booster in February. The results have been encouraging. Approximately one month later, most of her tumors had significantly shrunk, with one decreasing by around 75%, and Rosie regained much of her energy, even chasing rabbits again. “In December, she had little energy as the tumors represented a huge burden for her,” Conyngham recalled. “I don’t delude myself that this is a cure, but I believe this treatment has given Rosie a lot more time and quality of life.”
Thordarson believes this technology has the potential to “democratize” the design of personalized vaccines, as he explained in a post on X (formerly Twitter). However, he also cautioned that not all of Rosie’s nodules responded to the treatment and that rigorous clinical trials will be necessary before this approach can be widely applied to humans.
The development of this personalized vaccine represents a significant step forward in cancer treatment, demonstrating the potential of AI and mRNA technology to create targeted therapies. While further research is needed, Rosie’s case offers a beacon of hope for both animal and human patients battling cancer.
The success of Rosie’s treatment is prompting further investigation into the application of personalized mRNA vaccines for a wider range of cancers. Researchers are optimistic that this approach could lead to more effective and less toxic treatments for both pets and people. The future of cancer therapy may well be shaped by the lessons learned from this remarkable canine case.
Disclaimer: The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified veterinarian or healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the use of AI in veterinary medicine? Share your comments below!
